Page 1

24 February 2021 RECKITT BENCKISER ( RB.L ) STRONG PERFORMANCE UNDERPINS PROGRESS TOWARDS SUSTAINABLE GROWTH rb Q4 2020 FY 2020 £ m LFL1 Reported £ m LFL1 Reported Hygiene 1,589 + 25.7 % + 21.9 % 5,816 + 19.5 % + 15.6 % Health 1,171 + 2.8 % + 0.8 % 4,890 + 12.1 % + 9.6 % Nutrition 809 -3.5 % -5.5 % 3,287 unchanged -2.0 % Total 3,569 + 10.2 % + 7.5 % 13,993 + 11.8 % + 8.9 % £ m Constant FX1 Reported Operating Profit - Adjusted¹ 3,301 + 0.7 % Operating Profit Margin - Adjusted¹ 23.6 % -2.0 % -260bps Operating Profit - Reported 2,160 nm Operating Profit Margin - Reported 15.4 % nm 327.0p -6.3 % 159.3p nm 3,052 + 42.3 % 8,954 -17 % 1 Non - GAAP measures and definitions are defined on page 18 EPS ( diluted ) Adjusted¹ - EPS ( diluted ) - Reported² Free Cash Flow1 Net Debt¹ 2 Reported diluted EPS from continuing operations Full Year Financial Highlights * * * * * * * Group LFL net revenue up + 11.8 % : very strong , volume - led growth in a COVID environment , as consumers seek trusted , heritage brands , reinforced by stronger purpose - led brand equity and strengthened execution Hygiene LFL net revenue up + 19.5 % : very strong growth , particularly from Lysol and Finish , with broad - based growth in all regions and improved overall market share for Hygiene Health LFL net revenue up + 12.1 % : very strong Dettol growth in all major markets , strong growth from Gaviscon and improved Durex momentum , and improving market share performance overall Nutrition LFL net revenue unchanged : US IFCN growth and increased consumer focus on wellness and immunity , with Airborne up over 100 % , offset adverse IFCN market in Greater China e - Commerce : record full year channel growth of 56 % ; estimated to be c.12 % ¹ of group net revenue Full year adjusted operating margin of 23.6 % , in line with mid - year guidance Full year reported operating profit of £ 2,160m ( 2019 : reported operating loss of £ 1,954m ) . including IFCN goodwill impairment of £ 985m ( 2019 : £ 5,037m ) reflecting the volatility and uncertainties relating to COVID - 19 . * Adjusted diluted EPS of 327.0p ( 2019 : 349.0p ) * Record free cash flow generation of £ 3,052m ( 2019 : £ 2,145m ) reflecting negative net working capital position ; net debt reduced to £ 9.0bn ( 2019 : £ 10.7bn ) * Full Year Dividend of 174.6p ( 2019 : 174.6p ) , reflecting Board recommendation of a final dividend of 101.6p , and in line with policy and guidance from February 2020 Fourth Quarter Highlights * Group LFL net revenue growth of + 10.2 % ; Hygiene LFL growth of + 25.7 % , Health LFL growth of + 2.8 % , Nutrition LFL decline of -3.5 % 1